Chronic Lymphocytic Leukemia

Showing NaN - NaN of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Anemia
  • +2 more
  • Birmingham, Alabama
  • +795 more
Jan 28, 2023

Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

Recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • +3 more
  • clonoSEQ Assay
  • Stanford, California
  • +15 more
Jan 30, 2023

Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
Jan 16, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Obinutuzumab
  • +3 more
  • Birmingham, Alabama
  • +484 more
Aug 24, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Financial Difficulty in Chronic Lymphocytic Leukemia and

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Plasma Cell Myeloma
  • Medical Chart Review
  • +3 more
  • Anchorage, Alaska
  • +115 more
Aug 2, 2022

Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

Recruiting
  • Lymphoma, B-Cell
  • Chronic Lymphocytic Leukemia
  • Chicago, Illinois
  • +8 more
Jun 21, 2022

Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

Terminated
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
Apr 4, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Post-Chlorambucil Therapy Follow-up
  • +4 more
  • Duarte, California
  • +106 more
Aug 6, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +68 more
Mar 15, 2021

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Completed
  • Chronic Lymphocytic Leukemia
    • Pomona, California
    • +164 more
    May 8, 2020

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)

    Completed
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Birmingham, Alabama
    • +159 more
    Feb 20, 2020

    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Lymphoma, Non-Hodgkin
    • Huntsville, Alabama
    • +17 more
    Aug 22, 2019

    Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Duarte, California
    • +79 more
    Aug 5, 2019

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Chronic Lymphocytic Leukemia Trial in United States (alemtuzumab, rituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • alemtuzumab
    • rituximab
    • Scottsdale, Arizona
    • +101 more
    Dec 30, 2018

    Collecting and Storing Malignant, Borderline Malignant

    Completed
    • Acute Undifferentiated Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +191 more
    Jul 17, 2018

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)

    Completed
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Duarte, California
    • +107 more
    Nov 27, 2017

    Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States

    Terminated
    • Adult B Acute Lymphoblastic Leukemia
    • +28 more
    • Los Angeles, California
    • +6 more
    Aug 18, 2015